Thinner is better: Intentional weight loss and cardiovascular risk

Joseph Abraham; Javed Butler; Stefan D Anker

doi:10.1016/j.medj.2024.01.016

Thinner is better: Intentional weight loss and cardiovascular risk

Med. 2024 Apr 12;5(4):275-277. doi: 10.1016/j.medj.2024.01.016.

Authors

Joseph Abraham¹, Javed Butler², Stefan D Anker³

Affiliations

¹ Department of Internal Medicine, The Jewish Hospital, Cincinnati, OH, USA.
² Baylor Scott and White Research Institute, Dallas, TX, USA; University of Mississippi, Jackson, MS, USA.
³ Department of Cardiology (CVK) of German Heart Center Charité, German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany. Electronic address: [email protected].

PMID: 38614070
DOI: 10.1016/j.medj.2024.01.016

Abstract

The relationship between overweight/obesity and cardiovascular events needs to be tackled. The SELECT trial earns praise in showing that using GLP-1 receptor agonists to reduce overweight/obesity itself, in patients without dysglycemia, has beneficial effects on cardiovascular risk factors and clinical outcomes.¹.

MeSH terms

Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / prevention & control
Heart Disease Risk Factors
Humans
Obesity / epidemiology
Overweight
Risk Factors
Weight Loss